Prostate Cancer Incidence by Age and Clinicopathological Characteristics: A Population-Based Study in Girona, Spain, 2010 to 2021

dc.contributor.author
Sanvisens, Arantza
dc.contributor.author
Trallero, Jan
dc.contributor.author
Romaguera, Aina
dc.contributor.author
Puigdemont, Montserrat
dc.contributor.author
Vidal-Vila, Anna
dc.contributor.author
Comet i Batlle, Josep
dc.contributor.author
Marcos-Gragera, Rafael
dc.contributor.author
Serdà, Bernat-Carles
dc.date.accessioned
2026-01-21T14:08:41Z
dc.date.available
2026-01-21T14:08:41Z
dc.date.issued
info:eu-repo/date/embargoEnd/2026-12-19
dc.date.issued
2025-12-19
dc.identifier
http://hdl.handle.net/10256/28139
dc.identifier.uri
https://hdl.handle.net/10256/28139
dc.description.abstract
Purpose: The aim of this study is to determine the incidence of prostate cancer (PC) and its trends according to the age, Gleason grade (GG) and stage. Methods: Population-based study of PC cases diagnosed in Girona, Spain, from 2010 to 2021. Age at diagnosis, date and method of diagnosis, histology, Gleason score, and stage at diagnosis were collected. Poisson and negative binomial generalized linear models were used to estimate incidence trends and incidence rate ratios (IRRs), respectively. Results: Five thousand three hundred nine cases were included, with a median age of 70 years (IQR:64-77). The age standardized rates according to GG ranged from 12.8 cases per 100,000 men-year (m-y) for GG 5 to 36.6 cases for GG 2 and from 19.9 to 52.6 cases per 100,000 m-y for stages IV and II, respectively. Overall, there was a decline between 2010 and 2014, with an annual percentage change (APC) of 6.1% (95% CI, 9.0, 3.1), followed by stabilisation (APC: 0.3% [95% CI, 2.1, 1.5]). Adjusted IRRs for GG 3, 4, and 5 were lower than GG 1 and IRRs for stages III and IV were lower than stage I; however, the IRR for stage II was higher (IRR = 1.53 [95% CI, 1.40, 1.67]). Conclusions: Although the overall incidence of PC has remained stable since 2014, there has been an increase in cases with the worst prognosis. These cases usually involve elderly patients, who are the most vulnerable
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier
dc.relation
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clgc.2025.102492
dc.relation
info:eu-repo/semantics/altIdentifier/issn/1558-7673
dc.relation
info:eu-repo/semantics/altIdentifier/eissn/1938-0682
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/embargoedAccess
dc.source
© Clinical Genitourinary Cancer, 2025, art. núm. 102492
dc.source
Articles publicats (D-I)
dc.subject
Pròstata -- Càncer
dc.subject
Prostate -- Cancer
dc.subject
Epidemiologia
dc.subject
Epidemiology
dc.title
Prostate Cancer Incidence by Age and Clinicopathological Characteristics: A Population-Based Study in Girona, Spain, 2010 to 2021
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
dc.type
peer-reviewed


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.